Interaction of vitamin D, homocystein and dental diseases

Interaction of vitamin D, homocystein and dental diseases

The aim of the study was to estimate the effect of ursodeoxycholic acid (UDCA) on the lipid profile, endothelial dysfunction and insulin resistance in patients with coronary heart disease (CHD) in combination with non-alcoholic steatosis. Materials and methods. The group 1 consisted of 24 patient...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. V. Kuriata, M. M. Hrechanyk
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2019-06-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	coronary heart disease non-alcoholic fatty liver insulin resistance lipids vascular endothelium ursodeoxycholic acid
Online Access:	http://zmj.zsmu.edu.ua/article/view/169011/169285
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

Functional condition of vascular endothelium in patients with coronary heart disease in combination with non-alcoholic fatty liver disease, depending on weight and influence of statin therapy
by: O. V. Kuryata, et al.
Published: (2015-02-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

Dynamics of changes in lipid peroxidation and antioxidant protection under the influence of complex treatment in patients with comorbid course of non-alcoholic steatohepatitis
by: O. Yu. Filippova
Published: (2019-06-01)

Non-alcoholic fatty liver disease: a heterogeneous phenotype. Pleiotropic effects of ursodeoxycholic acid
by: E. A. Ljaljukova
Published: (2023-08-01)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016-01-01)

Ursodeoxycholic acid preparations in the complex treatment of non-alcoholic fatty liver disease and diabetes mellitus
by: U. A. Khalilova, et al.
Published: (2023-06-01)

How to avoid statin hepatotoxicity in patients with obesity and liver disease? Focus on the combination of ursodeoxycholic acid and atorvastatin
by: O. N. Korneeva, et al.
Published: (2012-12-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Metabolically associated fatty liver disease. What is the danger of a "safe" disease? Pathogenesis of cardiovascular complications
by: M. A. Isaikina, et al.
Published: (2025-02-01)

Comparative analysis of cardiometabolic parameters in patients with coronary heart disease with and without non-alcoholic fatty liver disease
by: Dilnora B. Yusupalieva, et al.
Published: (2025-06-01)

The use of pleiotropic effects of some gastroenterological drugs in the treatment of patients with non-alcoholic fatty liver disease and cardiovascular diseases: A review
by: Irina A. Komissarenko, et al.
Published: (2024-01-01)

Metabolic effects of ursodeoxycholic acid in patients with non-alcoholic fatty liver disease
by: V. A. Akhmedov
Published: (2024-04-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Role of bile acids in atherogenesis: review
by: A. S. Safaryan
Published: (2024-11-01)

SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION
by: S. N. Bel'diev
Published: (2017-03-01)

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease
by: I. I. Vakalyuk, et al.
Published: (2018-03-01)

Comparison of SPISE and METS-IR and Other Markers to Predict Insulin Resistance and Elevated Liver Transaminases in Children and Adolescents
by: Kyungchul Song, et al.
Published: (2025-03-01)

Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Chieh Liu, et al.
Published: (2025-07-01)

Investigation of the simultaneous effect of resistance training and atorvastatin in improving nonalcoholic fatty liver disease in Wistar rats fed high high-fat/fructose diet
by: Raouf Moradian, et al.
Published: (2025-05-01)

Efficiency and safety of application of combined scheme with ursodeoxycholic acid and mebeverin preparations in patients with metabolic syndrome
by: Yu. P. Uspensky, et al.
Published: (2021-06-01)

Clinical Significance of Serum Bile Acid Profiles in Fatty Liver
by: Sun HY, et al.
Published: (2024-12-01)

Dynamics of structural, functional and vegetative changes of heart under the influence of combined therapy with the use of ursodeoxycholic acid and L-arginine in patients with coronary heart disease associated with nonalcoholic fatty liver disease
by: N. S. Mykhailovska, et al.
Published: (2017-08-01)

Association between the triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus in non-alcoholic fatty liver disease
by: Liya Bian, et al.
Published: (2024-12-01)

Lipotoxicity and metabolic disorders at obesity
by: V. T. Ivashkin, et al.
Published: (2010-02-01)

The state of vascular endothelium, clinical and metabolic features of patients with coronary heart disease combined with nonalcoholic fatty liver disease
by: N. S. Mykhailovska, et al.
Published: (2017-04-01)

Metabolic syndrome correction in patients with non-alcoholic fatty liver disease and food behavior disorders
by: M. S. Yakovenko
Published: (2021-06-01)

Insulin Resistance Mediates the Association Between Vitamin D and Non-Alcoholic Fatty Liver Disease
by: Caiyan Zou, et al.
Published: (2024-12-01)

The level of plasma homocysteine in patients with non-alcoholic fatty liver disease in combination with type 2 diabetes
by: V. F. Orlovskiy, et al.
Published: (2015-06-01)

Nonalcoholic Fatty Liver Disease in Patients with Normal Body Weight: Epidemiology, Current Issues of Screening and Diagnosis, Approaches to Therapy
by: I. G. Nikitin, et al.
Published: (2025-07-01)

Therapeutic potential of Medical Nutrition Therapy (MNT) in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Abdul-Malik Bawah, et al.
Published: (2025-06-01)

Ursodeoxycholic acid therapy in children with cholestatic liver disease
by: Gönül Dinler, et al.
Published: (1999-01-01)

PECULIARITIES OF SYSTEMIС INFLAMMATION OF LOW INTENSITY IN PATIENTS WITH STABLE CORONARY HEART DISEASE CONCURRENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Yu.I. Manusha, et al.
Published: (2019-06-01)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
by: Evgenia Pavlovna Kosobyan, et al.
Published: (2010-03-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

Triglyceride glucose waist circumference and non alcoholic fatty liver disease: a systematic review and meta analysis
by: Ziyi Xin, et al.
Published: (2025-05-01)

Prevalence and association of non-alcoholic fatty liver disease and insulin resistance among non-diabetic obese, overweight, and metabolically obese normal-weight adult patients attending at a tertiary care hospital in Eastern India
by: Samik Pramanik, et al.
Published: (2025-02-01)

Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020
by: Bo Yang, et al.
Published: (2025-01-01)

The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
by: L. V. Bahnii, et al.
Published: (2023-04-01)

Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease
by: Jianhua Chen, et al.
Published: (2025-07-01)